EUVIMEDEUVIMED entdecken
Crossref

Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use

Gwang-Yee Jessica Hu, Niti Shah

AACN Advanced Critical Care · 15.03.2026 · 37 (1) · 6-14

DOI: 10.4037/aacnacc2026442 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AACN Advanced Critical Care, erschienen am 15.03.2026. Verfasst von Gwang-Yee Jessica Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gwang-Yee Jessica Hu is Clinical Assistant Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, t…. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Gwang-Yee Jessica Hu is Clinical Assistant Professor, Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, the State University of New Jersey, 160 Frelinghuysen Rd, Piscataway, N…
  • Niti Shah is Clinical Pharmacist, Critical Care, Department of Pharmacy, Morristown Medical Center, Atlantic Health System, Morristown, New Jersey.

Zitieren

APA

Hu, G. J., & Shah, N. (2026). Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use. AACN Advanced Critical Care, 37(1), 6-14. https://doi.org/10.4037/aacnacc2026442

Vancouver

Hu GJ, Shah N. Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use. AACN Advanced Critical Care. 2026;37(1):6-14. doi:10.4037/aacnacc2026442

BibTeX
@article{Hu2026,
  author = {Hu, Gwang-Yee Jessica and Shah, Niti},
  title = {Diabetic Ketoacidosis in the Era of Sodium-Glucose Cotransporter-2 Inhibitor Use},
  journal = {AACN Advanced Critical Care},
  year = {2026},
  volume = {37},
  number = {1},
  pages = {6--14},
  doi = {10.4037/aacnacc2026442}
}
Kostenlos starten →